Literature DB >> 17464464

Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C.

Naoki Fujita, Ryosuke Sugimoto, Naohito Urawa, Hideaki Tanaka, Masayoshi Konishi, Yoshinao Kobayashi, Motoh Iwasa, Shozo Watanabe, Masahiko Kaito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17464464     DOI： 10.1007/s00535-007-2004-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  9 in total

1.  Orchestration of iron homeostasis.

Authors:  Robert E Fleming; Bruce R Bacon
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 2.  Iron and chronic viral hepatitis.

Authors:  H L Bonkovsky; B F Banner; A L Rothman
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 3.  Therapy of hepatitis C: other options.

Authors:  H L Bonkovsky
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.

Authors:  Yusuke Kawamura; Norio Akuta; Hitomi Sezaki; Tetsuya Hosaka; Takashi Someya; Masahiro Kobayashi; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

5.  Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C.

Authors:  Masaki Takeo; Yoshinao Kobayashi; Naoki Fujita; Naohito Urawa; Motoh Iwasa; Shinichiro Horiike; Hideaki Tanaka; Masahiko Kaito; Yukihiko Adachi
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

Review 6.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

7.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

8.  A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.

Authors:  Motoyoshi Yano; Hisao Hayashi; Kentaro Yoshioka; Yutaka Kohgo; Hiroyuki Saito; Yoshiro Niitsu; Junji Kato; Shiro Iino; Hiroshi Yotsuyanagi; Yoshimasa Kobayashi; Kinya Kawamura; Shinichi Kakumu; Masahiko Kaito; Jiro Ikoma; Shinya Wakusawa; Takeshi Okanoue; Yoshio Sumida; Fumiaki Kimura; Eiji Kajiwara; Michio Sata; Kei Ogata
Journal:  J Gastroenterol       Date:  2004-06       Impact factor: 7.527

9.  Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats.

Authors:  David M Frazer; Sarah J Wilkins; Erika M Becker; Christopher D Vulpe; Andrew T McKie; Deborah Trinder; Gregory J Anderson
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682
  9 in total
  6 in total

1.  Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

Authors:  Jerzy Jaroszewicz; Magdalena Rogalska; Iwona Flisiak; Robert Flisiak
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

2.  Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.

Authors:  Motoyuki Kohjima; Tsuyoshi Yoshimoto; Munechika Enjoji; Nobuyoshi Fukushima; Kunitaka Fukuizumi; Tsukasa Nakamura; Miho Kurokawa; Nao Fujimori; Yusuke Sasaki; Yasushi Shimonaka; Yusuke Murata; Susumu Koyama; Ken Kawabe; Kazuhiro Haraguchi; Yorinobu Sumida; Naohiko Harada; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 4.  HCV and oxidative stress in the liver.

Authors:  Alexander V Ivanov; Birke Bartosch; Olga A Smirnova; Maria G Isaguliants; Sergey N Kochetkov
Journal:  Viruses       Date:  2013-01-28       Impact factor: 5.048

5.  Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C.

Authors:  Magdalena Rogalska-Taranta; Jerzy Jaroszewicz; Robert Flisiak
Journal:  Clin Exp Hepatol       Date:  2017-11-16

6.  Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.

Authors:  Anna Wróblewska; Agnieszka Bernat; Anna Woziwodzka; Joanna Markiewicz; Tomasz Romanowski; Krzysztof P Bielawski; Tomasz Smiatacz; Katarzyna Sikorska
Journal:  Clin Exp Med       Date:  2016-04-28       Impact factor: 3.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.